Soleno Therapeutics’ ‘life-changing’ drug nears approval decision

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox.

I can’t stop saying “loraz-a-payum” thanks to Parker Posey in “The White Lotus.”

Housekeeping note: I’ll be in New York City next week for STAT’s Breakthrough Summit East event on March 20. Therefore, this newsletter will take a one-week break. See ‘ya back on March 27.

STAT+ Exclusive Story

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Anesthesiologist-administered sedation improves discharge outcomes for patients after common procedures

Patients who had common procedures performed outside of the operating room (OR) were more likely to go home instead of to a long-term care facility

October 16, 2023

New AI approach enhances cardiovascular risk assessment

Risk calculators are used to evaluate disease risk for millions of patients, making their accuracy crucial.

September 24, 2024

‘Maternal aesthetics’ redefines self-confidence after birth – Biotech Investments

EQS-Media / 30.10.2023 / 13:26 CET/CEST Assoc. Prof. Dr. Z. Ulas Bali A remarkably high 79% of women grapple with body image concerns, and for

October 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.